 Vincent Chen
Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antipsychotic Agents | 3 | 2019 | 194 | 1.530 |
Why?
| | Taiwan | 9 | 2021 | 31 | 1.000 |
Why?
| | Global Burden of Disease | 5 | 2024 | 24 | 0.760 |
Why?
| | Antidepressive Agents | 4 | 2021 | 236 | 0.760 |
Why?
| | Liver Neoplasms | 4 | 2024 | 786 | 0.690 |
Why?
| | Carcinoma, Hepatocellular | 3 | 2018 | 362 | 0.670 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2021 | 413 | 0.630 |
Why?
| | Psoriasis | 1 | 2019 | 102 | 0.580 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2018 | 57 | 0.560 |
Why?
| | Taurine | 1 | 2018 | 46 | 0.560 |
Why?
| | Brain Mapping | 1 | 2021 | 503 | 0.560 |
Why?
| | Stomach Neoplasms | 1 | 2019 | 122 | 0.550 |
Why?
| | Methylphenidate | 1 | 2017 | 38 | 0.530 |
Why?
| | Accidents, Traffic | 1 | 2017 | 190 | 0.500 |
Why?
| | Enterovirus Infections | 1 | 2018 | 177 | 0.480 |
Why?
| | Dementia | 1 | 2019 | 259 | 0.470 |
Why?
| | Suicidal Ideation | 1 | 2021 | 529 | 0.470 |
Why?
| | Bipolar Disorder | 1 | 2017 | 263 | 0.450 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2018 | 293 | 0.430 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2024 | 93 | 0.410 |
Why?
| | Fractures, Bone | 1 | 2017 | 380 | 0.380 |
Why?
| | Incidence | 6 | 2024 | 2804 | 0.370 |
Why?
| | Infant, Premature | 1 | 2015 | 574 | 0.350 |
Why?
| | Mothers | 1 | 2015 | 754 | 0.310 |
Why?
| | Hospitalization | 1 | 2018 | 2199 | 0.290 |
Why?
| | Case-Control Studies | 4 | 2019 | 3556 | 0.290 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2015 | 847 | 0.270 |
Why?
| | Global Health | 3 | 2024 | 386 | 0.260 |
Why?
| | Databases, Factual | 4 | 2024 | 1357 | 0.260 |
Why?
| | Cohort Studies | 5 | 2021 | 5742 | 0.250 |
Why?
| | Male | 19 | 2024 | 67762 | 0.240 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2019 | 2057 | 0.240 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 93 | 0.230 |
Why?
| | Proportional Hazards Models | 2 | 2018 | 1266 | 0.220 |
Why?
| | Population Surveillance | 2 | 2019 | 482 | 0.220 |
Why?
| | Macrophage Activation | 1 | 2025 | 201 | 0.220 |
Why?
| | Logistic Models | 2 | 2019 | 2074 | 0.210 |
Why?
| | Female | 19 | 2024 | 73304 | 0.210 |
Why?
| | Phagocytosis | 1 | 2025 | 380 | 0.210 |
Why?
| | Comorbidity | 2 | 2019 | 1622 | 0.200 |
Why?
| | Humans | 27 | 2025 | 137585 | 0.200 |
Why?
| | Middle Aged | 11 | 2024 | 33479 | 0.200 |
Why?
| | Transcription Factors, TFIII | 1 | 2022 | 1 | 0.200 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 257 | 0.200 |
Why?
| | Thymus Neoplasms | 1 | 2022 | 25 | 0.200 |
Why?
| | Transcription Factors, TFII | 1 | 2022 | 41 | 0.190 |
Why?
| | Thymoma | 1 | 2022 | 36 | 0.190 |
Why?
| | Glioma | 2 | 2025 | 395 | 0.190 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2022 | 49 | 0.190 |
Why?
| | Cardiovascular Diseases | 3 | 2024 | 2111 | 0.190 |
Why?
| | Developing Countries | 1 | 2024 | 307 | 0.190 |
Why?
| | Aged | 7 | 2024 | 23961 | 0.180 |
Why?
| | Socioeconomic Factors | 2 | 2024 | 1289 | 0.180 |
Why?
| | Drug Therapy | 1 | 2021 | 85 | 0.170 |
Why?
| | Adolescent | 8 | 2024 | 21513 | 0.170 |
Why?
| | Alcoholism | 2 | 2024 | 807 | 0.170 |
Why?
| | Young Adult | 7 | 2024 | 13209 | 0.170 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2023 | 279 | 0.160 |
Why?
| | Adult | 11 | 2024 | 37929 | 0.160 |
Why?
| | Thalamus | 1 | 2021 | 107 | 0.160 |
Why?
| | Benzodiazepines | 1 | 2020 | 155 | 0.160 |
Why?
| | Hyponatremia | 1 | 2019 | 42 | 0.150 |
Why?
| | Hep G2 Cells | 1 | 2018 | 67 | 0.150 |
Why?
| | Odds Ratio | 2 | 2018 | 1070 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 900 | 0.150 |
Why?
| | Risk Factors | 3 | 2018 | 10388 | 0.150 |
Why?
| | Drug Prescriptions | 1 | 2020 | 245 | 0.150 |
Why?
| | Rats, Inbred WKY | 1 | 2018 | 36 | 0.150 |
Why?
| | Rats, Inbred SHR | 1 | 2018 | 45 | 0.150 |
Why?
| | Sodium | 1 | 2019 | 217 | 0.150 |
Why?
| | Cross-Sectional Studies | 3 | 2021 | 5472 | 0.140 |
Why?
| | Neostriatum | 1 | 2018 | 33 | 0.140 |
Why?
| | Enterovirus | 1 | 2018 | 86 | 0.140 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2018 | 89 | 0.140 |
Why?
| | Survivors | 1 | 2021 | 493 | 0.140 |
Why?
| | Lithium | 1 | 2017 | 43 | 0.140 |
Why?
| | Brain Neoplasms | 2 | 2025 | 1238 | 0.140 |
Why?
| | Macrophages | 1 | 2025 | 1547 | 0.140 |
Why?
| | Brain | 2 | 2021 | 2668 | 0.140 |
Why?
| | Depressive Disorder, Major | 1 | 2021 | 364 | 0.140 |
Why?
| | Cell Line, Tumor | 3 | 2025 | 3412 | 0.140 |
Why?
| | Prevalence | 4 | 2024 | 2734 | 0.140 |
Why?
| | Retrospective Studies | 7 | 2021 | 15657 | 0.130 |
Why?
| | Aorta | 1 | 2020 | 417 | 0.130 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2018 | 131 | 0.130 |
Why?
| | Aortic Valve | 1 | 2020 | 351 | 0.130 |
Why?
| | International Classification of Diseases | 1 | 2017 | 135 | 0.130 |
Why?
| | Corpus Striatum | 1 | 2018 | 167 | 0.130 |
Why?
| | Hepatitis B, Chronic | 1 | 2016 | 23 | 0.130 |
Why?
| | Risk | 1 | 2019 | 912 | 0.130 |
Why?
| | Brief Psychiatric Rating Scale | 1 | 2015 | 6 | 0.120 |
Why?
| | Sex Factors | 2 | 2019 | 2071 | 0.120 |
Why?
| | Substance-Related Disorders | 1 | 2024 | 1083 | 0.120 |
Why?
| | Renal Dialysis | 1 | 2019 | 435 | 0.120 |
Why?
| | Anticonvulsants | 1 | 2017 | 217 | 0.120 |
Why?
| | Dopamine | 1 | 2018 | 303 | 0.120 |
Why?
| | Prefrontal Cortex | 1 | 2018 | 301 | 0.120 |
Why?
| | Depressive Disorder | 1 | 2018 | 379 | 0.120 |
Why?
| | Child, Preschool | 3 | 2018 | 11074 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2019 | 383 | 0.110 |
Why?
| | Depression | 2 | 2021 | 1397 | 0.110 |
Why?
| | Infant | 2 | 2018 | 9465 | 0.100 |
Why?
| | Connexin 43 | 1 | 2013 | 32 | 0.100 |
Why?
| | Antineoplastic Agents, Alkylating | 1 | 2013 | 73 | 0.100 |
Why?
| | Dacarbazine | 1 | 2013 | 98 | 0.100 |
Why?
| | Machine Learning | 1 | 2018 | 493 | 0.100 |
Why?
| | Mitochondria | 2 | 2025 | 948 | 0.100 |
Why?
| | Computational Biology | 1 | 2017 | 644 | 0.100 |
Why?
| | Longitudinal Studies | 2 | 2017 | 2844 | 0.100 |
Why?
| | Myocardium | 1 | 2017 | 1002 | 0.100 |
Why?
| | Patient Compliance | 1 | 2016 | 581 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3566 | 0.090 |
Why?
| | Child | 4 | 2024 | 21935 | 0.090 |
Why?
| | Age Factors | 1 | 2019 | 3295 | 0.090 |
Why?
| | Early Detection of Cancer | 1 | 2016 | 447 | 0.090 |
Why?
| | Research Design | 1 | 2017 | 1139 | 0.090 |
Why?
| | Algorithms | 1 | 2018 | 1704 | 0.090 |
Why?
| | Rats | 1 | 2018 | 5647 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2021 | 2253 | 0.080 |
Why?
| | Liver Cirrhosis | 2 | 2023 | 316 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2018 | 4295 | 0.070 |
Why?
| | Alcohol Drinking | 2 | 2024 | 828 | 0.070 |
Why?
| | Registries | 1 | 2015 | 2035 | 0.070 |
Why?
| | Animals | 4 | 2025 | 36940 | 0.070 |
Why?
| | CD47 Antigen | 1 | 2025 | 38 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2017 | 6079 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 43 | 0.060 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 39 | 0.060 |
Why?
| | Apoptosis | 1 | 2013 | 2553 | 0.050 |
Why?
| | Phospholipases | 1 | 2023 | 14 | 0.050 |
Why?
| | Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2023 | 26 | 0.050 |
Why?
| | Acyltransferases | 1 | 2023 | 57 | 0.050 |
Why?
| | Metabolic Diseases | 1 | 2024 | 108 | 0.050 |
Why?
| | Mice | 3 | 2025 | 17787 | 0.050 |
Why?
| | Cost of Illness | 1 | 2024 | 308 | 0.050 |
Why?
| | Fatty Liver | 1 | 2024 | 243 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2023 | 455 | 0.040 |
Why?
| | Sexism | 1 | 2020 | 61 | 0.040 |
Why?
| | Signal Transduction | 1 | 2013 | 5079 | 0.040 |
Why?
| | Bias | 1 | 2020 | 218 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2015 | 3715 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 413 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2025 | 3015 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2025 | 2475 | 0.030 |
Why?
| | Mutation | 2 | 2022 | 3958 | 0.030 |
Why?
| | Pluripotent Stem Cells | 1 | 2017 | 80 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1431 | 0.030 |
Why?
| | Neuroimaging | 1 | 2018 | 259 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2023 | 2189 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2021 | 10811 | 0.030 |
Why?
| | Hemodynamics | 1 | 2020 | 1113 | 0.030 |
Why?
| | Liver | 1 | 2023 | 1943 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2023 | 2426 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 5757 | 0.030 |
Why?
| | Anxiety | 1 | 2021 | 1035 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2017 | 1178 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2015 | 230 | 0.030 |
Why?
| | Age of Onset | 1 | 2015 | 518 | 0.030 |
Why?
| | Annexin A5 | 1 | 2013 | 25 | 0.030 |
Why?
| | Fluoresceins | 1 | 2013 | 47 | 0.030 |
Why?
| | Tissue Engineering | 1 | 2017 | 423 | 0.030 |
Why?
| | Cytochromes c | 1 | 2013 | 60 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2017 | 526 | 0.030 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 617 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2847 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1313 | 0.020 |
Why?
| | Transfection | 1 | 2013 | 945 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 622 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1316 | 0.020 |
Why?
| | Phosphorylation | 1 | 2013 | 1759 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5778 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1291 | 0.020 |
Why?
| | Blood Glucose | 1 | 2015 | 2186 | 0.010 |
Why?
| | Insulin | 1 | 2015 | 2409 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2016 | 7635 | 0.010 |
Why?
| | Time Factors | 1 | 2013 | 6828 | 0.010 |
Why?
|
|
Chen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|